Abel Hall LLC’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
Abel Hall LLC's PGEN Position: Q3 2026 in Review
Abel Hall LLC increased its Precigen (PGEN) stake by 4.4% in Q3 2026, buying an estimated $3.27K and bringing the position to 11,727 shares worth $100K. The position accounts for 0.02% of the portfolio, ranked #778.
Abel Hall LLC first reported a position in PGEN in Q4 2025 and has held it in 4 quarters since. 60 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.
- Abel Hall LLC held 11,727 shares of Precigen worth $100K as of Q3 2026.
- Abel Hall LLC bought 498 Precigen shares in Q3 2026, an estimated $3.27K.
- Precigen made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #778 holding.
- Abel Hall LLC first reported a position in Precigen in Q4 2025 and has held it in 4 quarters since.
- 60 funds tracked by Wall St. Rank held Precigen as of Q3 2026.
Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.